Search form

 

Press Releases


Axcan Pharma to Present at Orion Securities' 11th Annual Healthcare Conference


Jun 15, 2006 - 10:00 ET

MONT SAINT-HILAIRE, QUEBEC--(CCNMatthews - June 15, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Thursday, June 22, 2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an overview of the Company at Orion Securities' 11th Annual Healthcare Conference to be held in Mont Tremblant, QC. This presentation will take place at 12:30 p.m. (Eastern time).

Axcan is a leading specialty pharmaceutical company involved in the field of gastroenterology. The Company markets a broad line of prescription products sold for the treatment of symptoms in a number of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to cystic fibrosis. Axcan's products are marketed by its own sales force in North America and Europe. Its common shares are listed on the Toronto Stock Exchange under the symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA".



Axcan Pharma Inc.
Isabelle Adjahi
Director, Investor Relations
(450) 467-2600 ext. 2000
www.axcan.com